Skip to main content

Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend

The biotech and healthcare space has been on fire lately. The healthcare space is witnessing a Mergers and Acquisitions wave recently that has achieved an impressive $342 billion in new deal activity so far in 2019. This has resulted in the best year by total deal value since tracking began in the...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.